Nitric oxide protects endothelial cells from tumor necrosis factor-α-mediated cytotoxicity: Possible involvement of cyclic GMP

FEBS Letters

Volumn 409, Issue 1, 1997, Pages 46-48

  Polte, Tobias ^a   Oberle, Stefanie ^a   Schröder, Henning ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Cyclic GMP; Cytoprotection; Endothelial cell; Nitric oxide; Tumor necrosis factor

Indexed keywords

8 BROMO CYCLIC GMP; CYCLIC GMP; GUANYLATE CYCLASE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CATTLE; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; IN VITRO STUDY; LUNG ARTERY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CATTLE; CELL LINE; CYCLIC GMP; CYTOTOXICITY, IMMUNOLOGIC; ENDOTHELIUM, VASCULAR; NITRIC OXIDE; PULMONARY ARTERY; SPERMINE; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; BOS TAURUS;

EID: 0030927423     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(97)00480-8     Document Type: Article

References (17)

1. Moncada S., Higgs E.A. Eur. J. Clin. Invest. 21:1991;361-374.
2. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Proc. Nat. Acad. Sci. USA. 88:1991;6368-6371.
3. Wink D.A., Hanbauer I., Krishna M.C., DeGraff W., Gamson J., Mitchell J.B. Proc. Nat. Acad. Sci. USA. 90:1993;9813-9817.
4. Motterlini R., Foresti R., Intaglietta M., Winslow R.M. Am. J. Physiol. 270:1996;H107-H114.
5. Wink D.A., Cook J.A., Pacelli R., DeGraff W., Gamson J., Liebmann J., Krishna M.C., Mitchell J.B. Arch. Biochem. Biophys. 331:1996;241-248.
6. Yee E.L., Pitt B.R., Billiar T.R., Kim Y.M. Am. J. Physiol. 271:1996;L512-518.
7. Oberle S., Schröder H. Exp. Toxic. Pathol. 48:1996;380-381.
8. Sato N., Goto T., Haranaka K., Satomi N., Nariuchi H., Mano-Hirano Y., Sawasaki Y. J. Nat. Cancer Inst. 76:1986;1113-1121.
9. Estrada C., Gomez C., Martin C., Moncada S., Gonzalez C. Biochem. Biophys. Res. Commun. 186:1992;475-482.
10. Schuger L., Varani J., Marks R.M., Kunkel S.L., Johnson K.J., Ward P.A. Lab. Invest. 61:1989;62-68.
11. Schröder H., Warren S., Bargetzi M.J., Torti S.V., Torti F.M. Naunyn-Schmiedeberg's Arch. Pharmacol. 347:1993;664-666.
12. Goossens V., Grooten J., De Vos K., Fiers W. Proc. Nat. Acad. Sci. USA. 92:1995;8115-8119.
13. Flick D.A., Gifford G.E. J. Immunol. Methods. 68:1984;167-175.
14. Akaike T., Maeda H. Methods Enzymol. 268:1996;211-221.
15. Kim Y.M., De Vera M.E., Watkins S.C., Billiar T.R. J. Biol. Chem. 272:1996;1402-1411.
16. Brunner F., Schmidt K., Nielsen E.B., Mayer B. J. Pharmacol. Exp. Ther. 277:1996;48-53.
17. Brüne B., Mohr S., Messmer U.K. Rev. Physiol. Biochem. Pharmacol. 127:1996;1-30.